Keytruda Post-Launch Patient Website Mar 10, 2018Mar 6, 2018 Brand: Keytruda (pembrolizumab), Injection Parent Company: Merck Drug Type: Prescription Drug Category: Oncology Campaign: Post-Launch Targeting: Patients, Caregivers Patient Website: https://www.keytruda.com/ HCP Website: https://www.keytruda.com/hcp/ Homepage Level 1 Page Patient Stories Patient Story Homepage (Mobile) Level 1 Page (Mobile)